CannabisNewsBreaks

ThursdayJul 25, 2019 10:34 am

CannabisNewsBreaks – Sproutly Canada Inc. (CSE: SPR) (OTCQB: SRUTF) (FRA: 38G) Announces THR Subsidiary Cannabis Cultivation Results that Outperform Design Capacity by 50%

Sproutly Canada (CSE: SPR) (OTCQB: SRUTF) (FRA: 38G) this morning announced recent cannabis production results at its wholly owned subsidiary Toronto Herbal Remedies Inc. (“THR”). According to the update, the total cultivation output of dry cannabis flower for the three-month period ended June 30, 2019, is 298kg compared to design capacity of 199kg. This represents overperformance of 49.9 percent versus design capacity. “The company has successfully achieved greater than expected results for the harvests from April to June 2019,” Sproutly Canada CEO Keith Dolo stated in the news release. “On a total of nine harvests, the average dry flower yield…

Continue Reading

ThursdayJul 25, 2019 9:41 am

CannabisNewsBreaks – Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) Expands Executive Team; Appoints New Chief Information Officer and VP of Talent

Supreme Cannabis Company (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) on Wednesday announced the appointment of its new Chief Information Officer ("CIO") Ash Rajendra, who will focus on ensuring the company is well prepared to execute on its next phase of growth. In addition, Supreme Cannabis announced that Valerie Rother has joined the company and will serve as its new VP, Talent, to steward its human capital and talent development program. “We are excited to welcome Mr. Rajendra and Ms. Rother to the Supreme Cannabis team. Both bring a wealth of experience and knowledge to drive the company's next phase of…

Continue Reading

WednesdayJul 24, 2019 10:39 am

CannabisNewsBreaks – MustGrow Biologics Corp (CSE: MGRO) Announces R&D Program to Build on Study Results, Future Testing of Second Generation Liquid Technology for Tobacco Agriculture

MustGrow Biologics (CSE: MGRO), an agricultural biotech company developing and commercializing a portfolio of natural biopesticides and biofertilizers, this morning announced that it will present its previous research findings in collaboration with Virginia Tech’s Southern Piedmont Agricultural Research and Extension Center in Blackstone, Virginia. According to the update, a program is underway to build on MustGrow’s encouraging scientific achievements, as well as advance corporate collaboration discussions with tobacco industry leaders. MustGrow’s recent appointment of Altria Group veteran Brian Quigley to its board of directors illustrates the company’s belief in this opportunity. To view the full press release, visit http://cnw.fm/b3EIp About…

Continue Reading

WednesdayJul 24, 2019 10:05 am

CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Enters Global Manufacturing & Licensing Partnership with Hill Street Beverage Co. (TSX.V: BEER)

Biotechnology company and drug delivery platform innovator Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP) today announced a multi-faceted expansion of its relationship with Hill Street Beverage Company Inc. (TSX.V: BEER). According to the update, the companies have entered into a 10-year Joint Manufacturing Partnership (“JMP”) to produce DehydraTECH(TM) commercial products under a new brand, which will be announced. The JMP will produce processed THC cannabis and/or CBD hemp powder for new consumer products under categories including, among others, tablets, capsules, or packets for sale in Canada and for export where permitted. Similar powders as a bulk ingredient for manufacturing processes will…

Continue Reading

WednesdayJul 24, 2019 9:28 am

CannabisNewsBreaks – IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) (FRA: IB3) Finalizes Acquisition of Zoots Premium Cannabis Infused Edibles

IONIC Brands (CSE: IONC) (OTC: IONKF) (FRA: IB3) this morning announced the successful completion of its acquisition of Washington-based Natural Extractions, Inc. d/b/a Zoots Premium Cannabis Infused Edibles. The total consideration for the purchase of Zoots is approximately US $11 million, comprised of US $855,000 cash and issuance of 9,635,150 common shares at C$1.30 per share to the vendors of Zoots, and the assumption of US $606,420 in outstanding debt. Additionally, the vendors have agreed to a lock-up agreement whereby up to 70% of the consideration shares are released over nine months. IONIC will also issue to the shareholders of…

Continue Reading

TuesdayJul 23, 2019 3:08 pm

CannabisNewsBreaks – Willow Biosciences Inc. (CSE: WLLW) Joint Development Agreement to Create Biosynthesis Platform for CBD Production, Distribution

Willow Biosciences (CSE: WLLW) recently entered a joint development agreement (“JDA”) with leading cannabinoid manufacturer Noramco Inc. to develop a yeast-based biosynthesis platform for the production and distribution of cannabidiol (“CBD”) (http://cnw.fm/KZdi0). An article further discussing the company reads, “The JDA is mutually exclusive and creates an enviable arrangement designed to take advantage of each company’s unique and compelling skill sets, the news release notes. The JDA requires each company to cover its own costs, retain its own intellectual property associated with its own scopes of work and share equally in the gross profits from sales of CBD produced under the…

Continue Reading

TuesdayJul 23, 2019 2:52 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Remains Ahead of the Pack with Innovative Delivery Technology

Biotechnology company Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP) is the developer of the drug-delivery platform DehydraTECH(TM). The company’s innovative technology promotes healthier ingestion methods, lower overall dosing and higher effectiveness of lipophilic active molecules. An article discussing the company reads, “One of the delivery challenges is the amount of CBD waste created, because the human body can only absorb a small amount of the molecules. DehydraTECH is disrupting this cycle by protecting the product during stomach transit, amplifying intestinal absorption by five to ten times over traditional methods and enabling the drug to bypass first-pass liver metabolism. Third-party lab studies…

Continue Reading

TuesdayJul 23, 2019 12:09 pm

CannabisNewsBreaks – Supreme Cannabis Company Inc.’s (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) New Investment Platform Targets UK, European CBD Health and Wellness Sector

Supreme Cannabis Company (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) recently launched a new investment platform called Supreme Heights. Established in London, the platform will capitalize on opportunities within the UK and European CBD health-and-wellness space. An article discussing the company reads, “While Supreme Heights has been initiated as a separate entity, the platform has solid foundational support and will benefit from Supreme Cannabis’ regulatory, product commercialization, supply chain, marketing and capital markets expertise, as well as corporate support services (http://cnw.fm/WgJ6O). Additionally, Supreme Heights will benefit from Supreme Cannabis’ experience launching premium brands and its team’s history of supporting health and wellness…

Continue Reading

MondayJul 22, 2019 10:31 am

CannabisNewsBreaks – Chemistree Technology Inc. (CSE: CHM) (OTCQB: CHMJF) Completes Investment in Applied Cannabis Sciences of New Jersey

Chemistree Technology Inc. (CSE: CHM) (OTCQB: CHMJF) this morning announced that, through a wholly owned U.S. subsidiary, it has finalized its investment into Applied Cannabis Sciences of New Jersey ("ACS"). The investment was previously announced in an April 15, 2019, press release as a letter of intent. According to the update, ACS will submit its application in the upcoming New Jersey round of Request for Applications (“RFA”), through which the state will issue 24 new permits comprising of 15 dispensary permits, 5 cultivation permits and 4 vertically integrated permits. "Completing this investment with ACS and being on the ground floor…

Continue Reading

MondayJul 22, 2019 9:40 am

CannabisNewsBreaks – Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) Announces PharmHouse JV’s Receipt of Health Canada Cultivation License

Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) this morning announced that PharmHouse Inc., its 49 percent-owned joint venture, has received a cultivation license from Health Canada. According to the update, PharmHouse will immediately commence operations in 190,000 sq. ft of licensed nursery infrastructure. In addition, the company plans to ramp up its entire 1.3 million sq. ft of ultramodern greenhouse space before the end of 2019 to deliver low-cost and high-quality cannabis and cannabis derivative products, both domestically and internationally, for Canopy Rivers’ ecosystem of partners. "This is a significant corporate milestone for Canopy Rivers. We believe the PharmHouse platform…

Continue Reading